Shares in Aortech, the up-for-sale heart valve developer, bounced 31% yesterday as the formerly Scottish medical technology group reported strong interest in the sale process.
Aortech, where one-time chief executive Eddie McDaid returned last year as finance director and former Edinburgh-based F&C fund manager Bill Brown is chairman, said 11 parties were running the rule over the company and the board was encouraged by the number who were progressing to due diligence or management presentations.
We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules, which are available here.
Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.
